Columns

More in this category

• Winning the lottery
• ERAS leads to reduced length of stay for geriatric joint replacement patients
• Modified FOLFIRINOX is superior to gemcitabine as adjuvant therapy for resected pancreatic cancer: The PRODIGE 24/CCTG PA6 Trial
• New Speak Up campaign focuses on patients’ rights
• Jennie Smillie Robertson, MD: One of Canada’s first women surgeons
• Looking forward – December 2019
• Caring: Isn’t that why we went to medical school?
• Letters to the Editor
• Medicare enrollment and participation
• Retained foreign bodies and wrong site surgery continue to be a challenge
• ERAS program improves outcomes in patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy
• ALCHEMIST trial has potential to improve outcomes after lung cancer resection
• Comparison of NCDB and CBTRUS demographic data for astrocytoma and glioblastoma
• Looking forward – November 2019
• ACS responds to frequently asked questions about CPT coding
• New protocol leads to improved trauma decannulation rate
• Moving the mark on harassment in surgical training
• Could axillary reverse mapping be useful in reducing surgical comorbidities?
• Matilda Arabella Evans, MD: Resolute, resilient, resourceful
• JAMA Surgery “Viewpoint” misrepresents Joint Commission’s role in the opioid epidemic